Literature DB >> 2668243

Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.

M Debono1, K E Willard, H A Kirst, J A Wind, G D Crouse, E V Tao, J T Vicenzi, F T Counter, J L Ott, E E Ose.   

Abstract

A series of 20-deoxo-20-cyclic (alkylamino) derivatives of tylosin, desmycosin, macrocin and lactenocin was prepared by reductive amination of the C-20 aldehyde group. The majority of the compounds were prepared using metal hydrides (sodium cyanoborohydride or sodium borohydride) as the reducing agents and a suitable cyclic alkylamine. Subsequently, a more convenient procedure was developed using formic acid as a reducing agent. The C-20 amino derivatives prepared from desmycosin exhibited good in vitro antimicrobial activity against Pasteurella haemolytica and Pasteurella multocida (MIC range of 0.78 approximately 6.25 micrograms/ml) as well as Mycoplasma species (MIC range of 0.39 approximately 6.25 micrograms/ml). Several derivatives showed excellent oral efficacy against infections caused by P. multocida in chicks. One of these derivatives, 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin or EL-870) was selected for development as a therapeutic agent for pasteurellosis in calves and pigs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668243     DOI: 10.7164/antibiotics.42.1253

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

Review 1.  Natural product discovery: past, present, and future.

Authors:  Leonard Katz; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-06       Impact factor: 3.346

2.  Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle.

Authors:  P E Gorham; L H Carroll; J W McAskill; L E Watkins; E E Ose; L V Tonkinson; J K Merrill
Journal:  Can Vet J       Date:  1990-12       Impact factor: 1.008

3.  A study of tilmicosin residues in milk following subcutaneous administration to lactating dairy cows.

Authors:  S L Helton-Groce; T D Thomson; R S Readnour
Journal:  Can Vet J       Date:  1993-10       Impact factor: 1.008

Review 4.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

5.  Animal-Use Antibiotics Induce Cross-Resistance in Bacterial Pathogens to Human Therapeutic Antibiotics.

Authors:  Atul K Singh; Arun K Bhunia
Journal:  Curr Microbiol       Date:  2019-07-25       Impact factor: 2.188

6.  Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity.

Authors:  Dražen Pavlović; Stjepan Mutak
Journal:  ACS Med Chem Lett       Date:  2011-03-15       Impact factor: 4.345

7.  5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.

Authors:  Akihiro Sugawara; Hitomi Maruyama; Sho Shibusawa; Hidehito Matsui; Tomoyasu Hirose; Ayumi Tsutsui; Robrecht Froyman; Carolin Ludwig; Johannes Koebberling; Hideaki Hanaki; Gerd Kleefeld; Satoshi Ōmura; Toshiaki Sunazuka
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

8.  Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.

Authors:  Tulay Avci; Muammer Elmas
Journal:  ScientificWorldJournal       Date:  2014-08-06

9.  Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.

Authors:  Zhen Dong; Xu-Zheng Zhou; Ji-Chao Sun; Xiao-Bin Meng; Hong-Sheng Li; Fu-Sheng Cheng; Xiao-Juan Wei; Bing Li; Wei-Wei Wang; Ji-Yu Zhang
Journal:  Vet Med Sci       Date:  2019-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.